Memorial Sloan-Kettering Cancer Center - NYC

New York, New York 10065

0 studies enrolling now · 3 studies all time

What they study most

Antimetabolites, Antineoplastic, Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, Endocrine System Diseases, Gemcitabine, Hematologic Neoplasms, Metastatic Castration-resistant Prostate Cancer, Neoplasms, Neoplasms by Site, Pancreatic Diseases, Pancreatic Neoplasms

Studies at this site

• FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Running, not enrolling
• Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation — Completed
• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) — Completed